To all those posters who have advocated pushing out Vivagel into approved markets consider this.
A product recall would be far more damaging to SPL than the chosen path to wait to all regions have given their approval and release world wide.
If you were currently a user of a product and then you heard that the worlds largest and most recognise agency had "questions" what doubt would that put in your mind.
Management have wisely played on the side of caution...
If you are an impatient investor, then move on this sector is not for you...
The FDA, their agendas and changing goal posts, page-42
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
